Authors: Juon Abbass, Sikandar Azam and Zeeshan Ahmad Butta
DOI: http://dx.doi.org/10.71081/cvj/2021.002
Abstract
Emerging and re-emerging viral infections have become the biggest threat to
humanity around the globe. Several viral diseases are pandemic in their
dissemination; the best prototype is the recent coronavirus-19 outbreak. There
is a diverse range of traditional identification, treatment, and prevention
methods for viral diseases that have been commonly used for so many years.
Certain limitations are associated with these techniques, such as high cost,
time consumption, poor accuracy, less sensitivity, and specificity. Recent
advancements in molecular biology exclusively in proteomics and genomics
have opened up a new arena for the more accurate and quick identification of
emerging viral infections and the better replacement of conventional methods
with newly developed pharmacological and biochemical strategies/tools for the
optimum treatment and prevention outcomes. In the present study, we have
thrown light on the more rapid molecular identification protocols for novel
viruses by taking into consideration the hybridization and PCR based
techniques and their efficiencies. Pharmacological and biochemical approaches
have been evaluated for treating viral infections by using potent antiviral drugs
such as Ribavirin, Remdesivir, Favipiravir, Tilorene, Hydroxychlorinequine,
and Nitazoxanide along with targeting the viral RNA, viral infectious and
membrane-less organelles, viral protein inhibition enzymes, host target
inhibition, and RNA silencing, respectively. Concerning prevention, various
specific and nonspecific immune boosters, including micronutrients,
probiotics, and synthetic peptides along with monoclonal antibodies and
vaccinations have been discussed. These latest approaches have proven very
much effective in the identification, treatment, and prevention of viral diseases
to save human beings and check their spread in the community
Keywords: Emerging Viruses, Micro-Array, Antiviral Drugs, Vaccines, Monoclonal antibodies